Project Flyer Project Flyer

Click here to download the project flyer Cardiorisk.

Consortium Consortium
 CARDIORISK Consortium

Main Focus Main Focus
The Project The Project
Impact Impact

Login Login


The Group - Consortium - Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology

Logo Cancer Center and Institute of Oncology, Gliwice

Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology
Branch Gliwice
Wybrzeze Armii Krajowej 15
44-101 Gliwice


Project Leader

Professor Dr. Piotr Widlak Professor Dr. Piotr Widlak
Phone: +48 32 278 96 72 
Fax: +48 32 231 35 12 
E-Mail to Professor Dr. Piotr Widlak Contact  

Project Staff

Dorota Gabrys, MD, PhD
Senior researcher 
E-Mail to Dorota Gabrys, MD, PhD Contact  

Karol Jelonek, M.Sc.
PhD Student 
E-Mail to Karol Jelonek, M.Sc. Contact  

Anna Walaszczyk
PhD Student 
E-Mail to Anna Walaszczyk Contact  

Institute Presentation

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology in Gliwice [IOG] is an European Comprehensive Cancer Center and one of the largest clinical institutions in Poland. The scientific staff of IOG comprises about 200 researchers and clinicians, including 13 full professors, 8 associate professors and about 70 PhD or MD/PhD researchers. The scientists are specialists in modern oncology, molecular and cell biology, radiobiology, nuclear medicine, medical physics.
The Research Division of IOG comprises the Departments of Tumor Biology, Molecular Biology, Experimental and Clinical Radiobiology, Epidemiology, Medical Physics and Nuclear Medicine. Its research staff is well recognized on the Polish and international research maps being involved in many aspects of basic, translational and clinical research in oncology since 1950. In 2004, the Research Division was awarded the title of "National Center of Excellence” by the Polish Ministry of Science.
Activity of the Research Division is devoted mainly to translational research in experimental oncology and pertains to molecular diagnostics and experimental therapies of cancer. Specifically, research activities are focused on: (i) genetic risk factor in cancer predisposition, (ii) novel prognostic and predictive markers for cancer therapy; (iii) genomic and proteomic signatures for cancer identification and classification; (iv) novel diagnostic tools for monitoring therapy; (v) pharmacology and biology of novel anticancer drugs; (vi) novel vectors and strategies of drug delivery. Another group of basic research projects is related mostly to molecular responses to cellular stress, including: (i) DNA damage and repair; (ii) heat shock response, (iii) cellular senescence and apoptosis.
Particularly strong areas of expertise are gene cloning, analysis of gene structure and function, transgenic mice, DNA microarrays, RT PCR, immunohistochemistry, confocal microscopy, polymorphic genes involved in metabolism of xenobiotics and DNA repair. Research groups cooperate actively with a team of mathematicians and computer scientists from the Silesian University of Technology in Gliwice, who specialize in biostatistics and mathematical analyses of biological phenomena. IOG is involved in graduate programs offered by three universities: the Silesian University (Faculties of Biology and Physics), the Silesian Medical University and the Silesian University of Technology.



Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology